Company Summary - Advanced Medical Solutions Group PLC (LSE:AMS)
32.00p
0.00p
FTSE AIM All Share Health Care Equipment & ServicesMarket cap: £46.405m
Review a company's summary page in more detail and see the key fundamentals at a glance. Sign-up to Premium now to make your investment decisions.
Sign-up to Premium's Free 7 Day trial See an improved company summary
Summary
Research, Development, Manufacture and Distribution of novel, high performance polymers for use as wound dressings
| Financials - Interim (8/9/2009) | ||
|---|---|---|
| Turnover | £m | 9.88 |
| Pre-tax Profit | £m | -0.05 |
| EPS | p | 0.77 |
| DPS | p | 0.00 |
| Director | Board Role |
|---|---|
| Dr. Geoffrey Vernon | Chairman |
| Dr. Don Evans | Chief Executive |
| Mary Tavener | Finance Director & Company Sec |
Products Brands & Subsidiaries
Products & Brands
Fenistil; Flexipore; Merfen; Mitraflex; Replicare; Savlon ActivHeal; Spyroflex; Trofolastin(R) Scar Reduction
Subsidiaries
Advanced Medical Solutions Ltd; Advanced Medical Solutions (UK) Ltd; MedLogic Global Holdings Ltd...
Broker Sentiment (3 brokers)
Strong SellStrong Buy
| Heading | Date |
|---|---|
| Total Voting Rights | 01/02/2010 |
| LiquiBand US Marketing Deal | 28/01/2010 |
| Appointment of COO | 19/01/2010 |